Loading...
•
Sep 30, 2021
Nu Skin Q3 2021 Earnings Report
Revenue decreased due to COVID-19 disruptions, but growth in the U.S. and Korea partially offset the decline.
Key Takeaways
Nu Skin Enterprises reported a decrease in revenue and EPS for Q3 2021 compared to the prior-year quarter, primarily due to COVID-19 related disruptions in Mainland China and Southeast Asia. However, growth in the U.S. and Korea provided some offset. The company is adjusting its 2021 forecast due to continued COVID uncertainty.
Q3 revenue was $641.2 million, a 9% decrease year-over-year.
EPS was $0.97, a 10% decrease year-over-year.
The company experienced growth in the U.S. driven by the Beauty Focus Collagen+ launch.
Double-digit growth was achieved in Korea due to successful product promotions and sales leader initiatives.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The company provided Q4 2021 revenue guidance of $645 to $675 million and EPS guidance of $0.90 to $1.00.
Positive Outlook
- Ongoing rollout of Collagen+ and ageLOC Meta products in Q4 will build momentum going into next year.
- Focus on vision of becoming the world’s leading beauty and wellness company.
- Introducing EmpowerMe personalized beauty and wellness strategy with connected beauty devices.
- Increasing adoption of affiliate-powered social commerce business model.
- Expanding digital platform.
Challenges Ahead
- Q4 2021 Revenue: $645 to $675 million; (10) to (14)%
- Approximately (1)% fx impact
- Q4 2021 EPS: $0.90 to $1.00; (29) to (36)%
- Prior year benefitted by 19.6% tax rate
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...